Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Microbot Medical Posts $15.1M Net Loss for Nine Months Ended Sept 2026

Microbot Medical Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing a net loss of $15,140 thousand for the nine months ended that date, along with its first recorded revenues and an accumulated deficit of $119,226 thousand.

Vinay Lochav | 13 November 2026

JATT III Acquisition Corp Files First 10-Q After August 2026 IPO

JATT III Acquisition Corp (NASDAQ:JTTT) filed its Form 10-Q for the quarter ended September 30, 2026, covering the company's initial period of operations following its inception on April 27, 2026 and the closing of its Initial Public Offering on August 27, 2026.

Manish Choudhary | 13 November 2026

Fabric.ai Reports Q3 2026 Net Loss of $4.9 Million

Fabric.ai, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 13, 2026, disclosing unaudited condensed consolidated financial results for the three and nine months ended September 30, 2026.

Nitish Kishor | 13 November 2026

Graf Global Corp. Reports Q3 2026 with $92.2M Trust

Graf Global Corp. filed its Form 10-Q for the quarter ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 13, 2026, disclosing financial results for the three and nine months ended September 30, 2026.

Aakashdeep | 13 November 2026

RMG ML Sports Holdings Q3 2026 10-Q: Trust Account Reaches $218.9M

RMG ML Sports Holdings filed its Form 10-Q for the quarter ended September 30, 2026 with the SEC on November 13, 2026, reporting financial results and balance sheet details for the period following its initial public offering.

Nitish Kishor | 13 November 2026

RMX Industries Posts $19.4M Net Loss for Nine Months Ended Sept 30, 2026

RMX Industries, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 13, 2026, reporting financial results for both the three and nine months ended on that date.

Shwetambri Chauhan | 13 November 2026

Silo Pharma Posts Q3 2026 Balance Sheet With $6.09M Cash

Silo Pharma, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 13, 2026, disclosing consolidated balance sheet data and financial results for the three and nine months ended September 30, 2026.

Vinay Lochav | 13 November 2026

Piermont Valley Acquisition Q2 FY2027: Net Loss $118,701

Piermont Valley Acquisition Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026, disclosing a six-month net loss of $118,701 and a total shareholders' deficit of $1,638,164 as of that date.

Manish Choudhary | 13 November 2026

CirTran Q3 2026: Net Sales Rise, Deficit Narrows

CirTran Corporation filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the SEC on November 13, 2026, disclosing a net loss from continuing operations of $272,618 for the third quarter alongside a nine-month net income of $1,827,615 driven …

Vinay Lochav | 13 November 2026

KPET Ultra Paceline Q3 2026: $233.8M in Trust

KPET Ultra Paceline Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 13, 2026, reporting $233,825,777 held in its Trust Account and net income of $1,954,910 for the three months ended September 30, 2026.

Manish Choudhary | 13 November 2026
Support

Hi! How can we help you today?

Loading…